Clinical Trial Update: Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN) [NA]

View source ↗

Summary

This clinical trial update announces the feasibility and evaluation study of the POINT-GUARD Embolic Protection Device during transcatheter aortic valve replace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• POINT-GUARD Embolic Protection Device

Snippet

Sponsor: Transverse Medical, Inc. | Conditions: Transcatheter Aortic Valve Implantation (TAVI), Aortic Valve Stenosis | NA | Status: RECRUITING